Skip to main content
. 2019 Oct 24;12:791–798. doi: 10.2147/CCID.S216222

Table 5.

Treatment-Related Adverse Events

Treatment-Related Adverse Events
Subjects with treatment-related adverse events, n/N (%) 20/131 (15.3)
Event, n (%)
 Injection site mass 12 (9.2)
 Injection site bleeding 4 (3.1)
 Injection site hematoma 3 (2.3)
 Injection site erythema 1 (0.8)
 Injection site nodule 1 (0.8)